Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Viral Mutations00:36

Viral Mutations

32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

3.6K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A single autoregressive integrated moving average with exogenous variable outperforms ensembles of autoregressive models for forecasting influenza hospitalizations in the contiguous United States.

Journal of the Royal Society, Interface·2026
Same author

Can vaccine-preventable disease resurgence be anticipated? Leading indicators and tipping points.

Future microbiology·2026
Same author

No evidence for critical slowing down before measles outbreaks in the US, 2006-2025.

Future microbiology·2026
Same author

Physics-informed deep learning for infectious disease forecasting.

Journal of the Royal Society, Interface·2025
Same author

Collateral effects of COVID-19 pandemic control on the US infectious disease landscape.

Science (New York, N.Y.)·2025
Same author

Natural immune boosting biases pertussis infection estimates in seroprevalence studies.

Nature communications·2025

Related Experiment Video

Updated: Jun 23, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.7K

Pertussis vaccines, epidemiology and evolution.

Matthieu Domenech de Cellès1, Pejman Rohani2,3,4

  • 1Infectious Disease Epidemiology Group, Max Planck Institute for Infection Biology, Berlin, Germany.

Nature Reviews. Microbiology
|June 21, 2024
PubMed
Summary

Pertussis (whooping cough) remains a threat, with recent resurgences in vaccinated populations. This review explores the complex immunology and epidemiology of Bordetella pertussis, aiming to explain current challenges.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.2K

Related Experiment Videos

Last Updated: Jun 23, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.7K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.2K

Area of Science:

  • Immunology
  • Epidemiology
  • Evolutionary Biology

Background:

  • Pertussis, caused by Bordetella pertussis, is a highly infectious disease with a long history.
  • While whole-cell pertussis (wP) vaccines drastically reduced incidence, concerns over reactogenicity led to acellular (aP) vaccines.
  • Recent pertussis resurgences in countries with high aP coverage have sparked debate.

Purpose of the Study:

  • To review the complexities of contemporary pertussis epidemiology and immunology.
  • To address controversies surrounding natural and vaccine-derived immunity duration and effectiveness.
  • To propose explanations for incongruous observations in pertussis resurgence.

Main Methods:

  • Review of existing literature on pertussis immunology, epidemiology, and bacterial evolution.
  • Analysis of factors contributing to pertussis resurgence despite vaccination.
  • Discussion of challenges in pertussis surveillance and diagnosis.

Main Results:

  • Controversy exists regarding vaccine effectiveness in preventing transmission and severe disease.
  • Bordetella pertussis evolution may impact vaccine-induced immunity.
  • Incomplete case detection and diagnostic heterogeneity complicate understanding.

Conclusions:

  • Understanding pertussis requires addressing complexities in immunity, transmission, and bacterial evolution.
  • Further research is needed to resolve debates on vaccine efficacy and pertussis resurgence.
  • A parsimonious explanation for current pertussis challenges is proposed.